StonvexLoading…
StonvexStonvexStonvexCore line items from DUOL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.04B | $748.02M | $531.11M | $369.50M |
Operating Income | $135.57M | $62.59M | $-13.26M | $-65.19M |
Net Income | $414.06M | $88.57M | $16.07M | $-59.57M |
EPS (Diluted) | $8.57 | $1.88 | $0.35 | $-1.51 |
Total Assets | $1.99B | $1.30B | $953.96M | $747.35M |
Total Liabilities | $645.18M | $477.18M | $298.46M | $205.27M |
Cash & Equivalents | $1.04B | $785.79M | $747.61M | $608.18M |
Free Cash Flow OCF − CapEx | $369.73M | $273.40M | $150.42M | $48.09M |
Shares Outstanding | 48.31M | 47.10M | 46.52M | 39.47M |